Prism Peptides
MOTS - C
MOTS - C
Couldn't load pickup availability
š“ IMPORTANT: Read This Before Proceeding With Dosing
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c)
MOTS-C is a mitochondrial-encoded peptide that plays a critical role in metabolic regulation, insulin sensitivity, and mitochondrial health. It is naturally upregulated during exercise and is therefore considered an exercise mimeticāa compound that mimics the beneficial physiological effects of physical activity.
MOTS-C levels decline significantly with age, contributing to insulin resistance, metabolic dysfunction, mitochondrial stress, and reduced NAD+ activity. Supplementation is commonly researched in individuals with obesity, metabolic syndrome, diabetes, cardiovascular disease, and age-related decline.
āļø Mechanism of Action (Simplified)
- Improves glucose uptake in skeletal muscle
- RegulatesĀ mitochondrial fission and fusion
- ReducesĀ mitochondrial oxidative stress
- SupportsĀ metabolic flexibility
- Interacts withĀ nuclear genes involved in aging and metabolic disease
- Acts downstream of exercise-induced signaling pathways
⨠Benefits
Supports weight loss & fat oxidation
Increases metabolic rate
Reduces visceral & liver fat
Improves insulin sensitivity
Protects against metabolic disorders (e.g., NASH)
Enhances physical performance & endurance
Improves muscle function
- Cardiovascular protection & reduced vascular calcification
- Neuroprotective (may delay Alzheimerās progression)
- Protects against macular degeneration
- Anti-inflammatory & immunoregulatory effects
- Mitigates chemotherapy-induced side effects
- Inhibits inflammatory painAntimicrobial activity (including MRSA)
- Improves survival in severe infections / sepsisLongevity & healthy aging support
ā ļø Possible Side Effects
- Injection-site redness, swelling, or itching
- Headache
- Mild GI discomfort
Rare: oxidative stress or tissue fatigue with overuse.
These are typically dose-dependent.
š Synergistic Peptides
- SS-31 ā Highly recommended prior to MOTS-C
- Humanin
- Frag 176-292
- Tesofensine
Best practice: Cycle SS-31 first to prime mitochondrial membranes, then follow with MOTS-C.
š§ RECONSTITUTION & DOSING PROTOCOLS
š§Ŗ MOTS-C ā 10 mg Vial
Reconstitution:
- Mix with 0.5 mL (50 units) bacteriostatic water
- Concentration: 1 mg = 5 units
- Administration: Subcutaneous
š¢ STANDARD PROTOCOLS
ā 20-Day Protocol ā 20 mg total
- Dose: 5 mg (25 units)
- Frequency:Ā Once every 5 days
- Injections:Ā 4 total
- Total used: 20 mg
Vials Needed
- 10 mg vials: 2 vials
ā 30-Day Protocol ā 40 mg total
- Dose: 10 mg (50 units)
- Frequency:Ā Once weekly
- Injections:Ā 4 total
- Total used: 40 mg
Vials Needed
-
40 mg vial: 1 vial ā (best choice)
š“ MAXIMUM PROTOCOLS
ā” 4-Week Intensive Cycle ā 60 mg total
- Dose: 5 mg (25 units)
- Frequency: 3Ć per week
- Total used: 60 mg
Vials Needed
- 10 mg vials: 6 vials
- 40 mg vials: 2 vials (80 mg total ā buffer)
ā” 6-Week Intensive Cycle ā 90 mg total
- Dose: 5 mg (25 units)
- Frequency:Ā 3Ć per week
- Total used: 90 mg
Vials Needed
- 10 mg vials: 9 vials
- 40 mg vials: 3 vials (120 mg total ā buffer)
š 10-Week Protocol ā 100 mg total
- Dose: 10 mg (50 units)
- Frequency:Ā Once weekly
- Injections:Ā 10 total
- Total used: 100 mg
Vials Needed
- 10 mg vials: 10 vials
- 40 mg vials: 3 vials (120 mg total ā buffer)
š Quick Summary Table
| Protocol | Total mg | 10 mg Vials | 40 mg Vials | Best Choice |
|---|---|---|---|---|
| 20-day standard | 20 mg | 2 | ā | 10 mg |
| 30-day standard | 40 mg | 4 | 1 | 40 mg ā |
| 4-week intensive | 60 mg | 6 | 2 | 40 mg |
| 6-week intensive | 90 mg | 9 | 3 | 40 mg |
| 10-week max | 100 mg | 10 | 3 | 40 mg ā |
š Practical Notes
- 40 mg vials are more efficient for anything beyond light cycles
- Extra buffer accounts forĀ priming loss, dead space, and spillage
- Store reconstituted vialsĀ refrigerated and use within 30ā45 days
š Cycling Guidelines
- Typical cycles: 20 days to 10 weeks
- Do not run continuously year-round
- AllowĀ at least 8ā12 weeks off between aggressive cycles
- SS-31 should precede each MOTS-C cycle when possible
š Stacking Suggestions
| Stack | Purpose |
|---|---|
| SS-31 ā | Mitochondrial priming (best used first) |
| Humanin | Cell protection & longevity synergy |
| Tesofensine | Enhanced fat loss & metabolic output |
| AOD-9604 | Additional lipolysis |
| CJC-1295 / Ipamorelin | GH pathway & recovery |
| BPC-157 / TB-500 | Muscle preservation & inflammation control |
| Glutathione / NAD+ precursors | Antioxidant & mitochondrial support |
š Why Choose MOTS-C?
- True mitochondrial peptide, not synthetic hormone mimicry
- AddressesĀ aging at the cellular energy level
- Ideal for users whoĀ canāt exercise intensely
- Powerful metabolic and longevity support
- Complements weight-loss peptides without appetite suppression
š§ Storage
- Refrigerate after reconstitution
- Use withinĀ 30ā45 days
Share
